Economic Evaluation of the Use of FeNO for the Diagnosis and Management of Asthma Patients in Primary Care in Sweden

References

• Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention; 2019. Available from: https://ginasthma.org/wp-content/uploads/2019/06/GINA-2019-main-report-June-2019-wms.pdf. Accessed November 18, 2019.
   Google Scholar
• Gibson GJ, Loddenkemper R, Sibille Y, Lundbäck B, Fletcher M. Lung health in Europe – facts and figures: a better understanding of lung disease and respiratory care in Europe. European Lung Foundation (ELF); 2013. Available from: https://www.europeanlung.org/assets/files/publications/lung_health_in_europe_facts_and_figures_web.pdf. Accesssed November 19, 2019.
   Google Scholar
• Bahadori K, Doyle-Waters MM, Marra C, et al. Economic burden of asthma: a systematic review. BMC Pulm Med. 2009;9(1). doi:10.1186/1471-2466-9-24
   Google Scholar
• Jansson SA, Rönmark E, Forsberg B, et al. The economic consequences of asthma among adults in Sweden. Respir Med. 2007;101(11):2263–2270. doi:10.1016/j.rmed.2007.06.029
   PubMed Web of Science ®Google Scholar
• Socialstyrelsen. Nationella riktlinjer för vård vid astma och KOL. [National guidelines for the treatment of asthma and COPD]. Swedish; 2018. Available from: https://www.socialstyrelsen.se/globalassets/sharepoint-dokument/artikelkatalog/nationella-riktlinjer/2018-1-36.pdf. Accessed November 18, 2019.
   Google Scholar
• Statistiska centralbyrån (SCB). Sveriges framtida befolkning 2018–2070. [The future population of Sweden 2018–2070]. Swedish; 2018. Available from: https://www.scb.se/contentassets/b3973c6465b446a690aec868d8b67473/be0401_2018i70_br_be51br1801.pdf. Accessed November 18, 2019.
   Google Scholar
• Karrasch S, Linde K, Rücker G, et al. Accuracy of FENO for diagnosing asthma: a systematic review. Thorax. 2017;72(2):109–116. doi:10.1136/thoraxjnl-2016-208704
   PubMed Web of Science ®Google Scholar
• Smith AD, Cowan JO, Filsell S, et al. Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med. 2004;169(4):473–478. doi:10.1164/rccm.200310-1376OC
   PubMed Web of Science ®Google Scholar
• Berkman N, Avital A, Breuer R, Bardach E, Springer C, Godfrey S. Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests. Thorax. 2005;60(5):383–388. doi:10.1136/thx.2004.031104
   PubMed Web of Science ®Google Scholar
• Hunter CJ, Brightling CE, Woltmann G, Wardlaw AJ, Pavord ID. A comparison of the validity of different diagnostic tests in adults with asthma. Chest. 2002;121(4):1051–1057. doi:10.1378/chest.121.4.1051
   PubMed Web of Science ®Google Scholar
• Gallmeier K, Becker E, Kirsten A, et al. Prediction of new-onset asthma and nasal allergy by skin prick test and RAST in a cohort of adults. Eur Respir J. 2014;43(1):92–102. doi:10.1183/09031936.00012813
   Web of Science ®Google Scholar
• Donohue JF, Jain N. Exhaled nitric oxide to predict corticosteroid responsiveness and reduce asthma exacerbation rates. Respir Med. 2013;107(7):943–952. doi:10.1016/j.rmed.2013.02.018
   PubMed Web of Science ®Google Scholar
• Syk J, Malinovschi A, Johansson G, et al. Anti-inflammatory treatment of atopic asthma guided by exhaled nitric oxide: a randomized, controlled trial. J Allergy Clin Immunol Pract. 2013;1(6):639–648. doi:10.1016/j.jaip.2013.07.013
   Web of Science ®Google Scholar
• Tandvårds- och läkemedelsförmånsverket (TLV). Drug price database. Available from: https://www.tlv.se/beslut/sok-i-databasen.html. Accessed December 2, 2019.
   Google Scholar
• Ställberg B, Lisspers K, Hasselgren M, et al. Asthma control in primary care in Sweden: a comparison between 2001 and 2005. Prim Care Respir J. 2009;18(4):279–286. doi:10.4104/pcrj.2009.00024
   PubMedGoogle Scholar
• Intramedic AB. Intramedic AB web page. Available from: https://www.intramedic.se/about-us/. Accessed December 2, 2019
   Google Scholar
• NIOX VERO®. NIOX web page. Available from: https://www.niox.com/en/niox-vero/about-niox-vero/. Accessed December 2, 2019.
   Google Scholar
• Lane S, Molina J, Plusa T. An international observational prospective study to determine the cost of asthma exacerbations (COAX). Respir Med. 2006;100(3):434–450. doi:10.1016/j.rmed.2005.06.012
   PubMed Web of Science ®Google Scholar
• Enilari O, Sinha S. The global impact of asthma in adult populations. Ann Glob Health. 2019;85(1):2. doi:10.5334/aogh.2412
   PubMed Web of Science ®Google Scholar
• Price D, Berg J, Lindgren P. An economic evaluation of NIOX MINO airway inflammation monitor in the United Kingdom. Allergy. 2009;64(3):431–438. doi:10.1111/j.1398-9995.2008.01855.x
   PubMed Web of Science ®Google Scholar
• Berg J, Lindgren P. Economic evaluation of FE(NO) measurement in diagnosis and 1-year management of asthma in Germany. Respir Med. 2008;102(2):219–231. doi:10.1016/j.rmed.2007.09.008
   Web of Science ®Google Scholar
• Harnan SE, Tappenden P, Essat M, et al. Measurement of exhaled nitric oxide concentration in asthma: a systematic review and economic evaluation of NIOX MINO, NIOX VERO and NObreath. Health Technol Assess. 2015;19(82):1–330. doi:10.3310/hta19820
   Web of Science ®Google Scholar
• Mgaloblishvili N, Gotua M. Modern approaches to fractional exhaled nitric oxide as a useful biomarker for allergic asthma phenotyping and management. Georgian Med News. 2017;273:51–55.
   Google Scholar
• Truong-Thanh T, Vo-Thi-Kim A, Vu-Minh T, Truong-Viet D, Tran-van H, Duong-Quy S. The beneficial role of FeNO in association with GINA guidelines for titration of inhaled corticosteroids in adult asthma: a Randomized Study. Adv Med Sci. 2020;65(2):244–251. doi:10.1016/j.advms.2020.03.001
   PubMed Web of Science ®Google Scholar
• Dinh-Thi-Dieu H, Vo-Thi-Kim A, Tran-van H, Tang-Thi-Thao T, Duong-Quy S. Study of the beneficial role of exhaled nitric oxide in combination with GINA guidelines for titration of inhaled corticosteroids in children with asthma. J Breath Res. 2020;14(2):026014. doi:10.1088/1752-7163/ab6809
   PubMed Web of Science ®Google Scholar
• Duong-Quy S, Nguyen-Thi-Bich H, Le-thi-minh H, Timothy C. The use of exhaled nitric oxide (NO) to categorize asthma phenotype and treatment in children - results from national hospital of pediatrics. Eur Respir J. 2018;52(suppl 62):PA1315.
   Google Scholar
• Sabatelli L, Seppälä U, Sastre J, Crater G. Cost-effectiveness and budget impact of routine use of fractional exhaled nitric oxide monitoring for the management of adult asthma patients in Spain. J Investig Allergol Clin Immunol. 2017;27(2):89–97. doi:10.18176/jiaci.0103
   PubMed Web of Science ®Google Scholar
• Brooks EA, Massanari M. Cost-effectiveness analysis of monitoring fractional exhaled nitric oxide (FeNO) in the management of asthma. Manag Care. 2018;27(7):42–48.
   Google Scholar
• LaForce C, Brooks E, Herje N, Dorinsky P, Rickard K. Impact of exhaled nitric oxide measurements on treatment decisions in an asthma specialty clinic. Ann Allergy Asthma Immunol. 2014;113(6):619–623. doi:10.1016/j.anai.2014.06.013
   PubMed Web of Science ®Google Scholar
• Bukstein D, Luskin AT, Brooks EA. Exhaled nitric oxide as a tool in managing and monitoring difficult-to-treat asthma. Allergy Asthma Proc. 2011;32(3):185–192. doi:10.2500/aap.2011.32.3449
   PubMed Web of Science ®Google Scholar